Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Z-Dex vs VAD Induction Therapy for Multiple Myeloma
NCT00006232Phase 3Completed
- Sponsor
- West of Scotland Lymphoma Group
- Start
- Oct 1996
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of idarubicin in multiple myeloma (MM), sponsored by West of Scotland Lymphoma Group. Started Oct 1996; status: completed.
02
Drugs
idarubicin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00006232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006232.